About Us
Welcome to Maculaser, where innovation meets compassion in the realm of retinal care. Our groundbreaking retinal treatment leverages personalized heating to awaken the natural healing response of senescent cells. With a dedicated focus on disease prevention, we provide a non-damaging solution to address retinal disorders that impact millions globally.
Our Vision
Rooted in pioneering research in the top biomedical engineering laboratory at Aalto University, Finland, since 2013, Maculaser aims to revolutionize retinal healthcare. Targeting conditions like Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and Central Serous Chorioretinopathy (CSC), we strive to tackle the root causes of the diseases and make prevention a cornerstone of eye care. Our journey is advancing towards initiating our clinical trials.
Company Values
Focusing on patient safety, committed to science and evidence-based approaches, driven by outcome orientation, and inspired by engineering curiosity, our company values guide us to innovate and improve healthcare solutions. Each principle is integral to our dedication to advancing medical technology with integrity, precision, and a forward-thinking mindset.
Our Team
Jani Tirronen
CEO
Teemu Turunen
Chief Scientific Officer, PhD
Ossi Kaikkonen
Head of Product
Jaakko Nieminen
CTO, PhD
Kirsty Happonen
Head of RAQA
Risto Montonen
Senior R&D Engineer, PhD
Contact us
Follow how our solution develops
-
Maculaser’s retinal treatment technology exhibited in Media
Finnish new technology focused magazine T&T (Tekniikka ja Talous) reports on Maculaser’s goals and timeline in developing novel treatments for […]
-
New Head of Regulatory Affairs and Quality Assurance joins the team
We are excited to announce that Kirsty Happonen joins the Maculaser team as Head of Regulatory Affairs and Quality Assurance. Kirsty […]
-
General Application
We are seeking talented professionals to advance our mission of preventing blindness